Certain patient characteristics may increase the likelihood of developing pancreatitis while taking GLP-1 receptor agonists, though these same factors elevate risk regardless of medication use
For patients using compounded semaglutide, consider discussing FDA-approved formulations (Ozempic or Wegovy) with your healthcare provider to ensure consistent quality, safety, and regulatory oversight
While there may be concerns over the rise in calls to poison control centres in both countries, Wharton said with more use will come improvements to dosing
Our team evaluates each patients medical history, current health status, and weight loss goals to determine if GLP-1 therapy is appropriate
The potential role of incretin hormones has been thoroughly studied in different metabolic conditions, but data about women with PCOS and CAH are insufficient